Solid Biosciences Inc [SLDB] stock prices are up 12.62% to $9.64 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SLDB shares have gain 44.74% over the last week, with a monthly amount glided 13.28%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Solid Biosciences Inc [NASDAQ: SLDB] stock has seen the most recent analyst activity on July 15, 2024, when JP Morgan upgraded its rating to a Overweight and also boosted its price target to $15 from $10. Previously, Leerink Partners upgraded its rating to Outperform on June 24, 2024, and kept the price target unchanged to $12. William Blair started tracking the stock assigning a Outperform rating and suggested a price target of $40 on March 28, 2024. Citigroup initiated its recommendation with a Buy and recommended $16 as its price target on March 15, 2024. Piper Sandler upgraded its rating to Overweight for this stock on March 14, 2024, and upped its price target to $20. In a note dated December 08, 2023, H.C. Wainwright initiated an Buy rating and provided a target price of $9 on this stock.
The stock price of Solid Biosciences Inc [SLDB] has been fluctuating between $1.81 and $15.05 over the past year. Currently, Wall Street analysts expect the stock to reach $17.5 within the next 12 months. Solid Biosciences Inc [NASDAQ: SLDB] shares were valued at $9.64 at the most recent close of the market. An investor can expect a potential return of 81.54% based on the average SLDB price forecast.
Analyzing the SLDB fundamentals
Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at -20.92%, Pretax Profit Margin comes in at -19.06%, and Net Profit Margin reading is -19.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.36, Equity is -0.56 and Total Capital is -0.42. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.95 points at the first support level, and at 8.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.29, and for the 2nd resistance point, it is at 10.95.
Ratios To Look Out For
It’s worth pointing out that Solid Biosciences Inc [NASDAQ:SLDB]’s Current Ratio is 14.94. Further, the Quick Ratio stands at 14.94, while the Cash Ratio is 8.2.
Transactions by insiders
Recent insider trading involved Kahn Clare, Director, that happened on Jun 07 ’24 when 1100.0 shares were purchased. Director, Ganot Ilan completed a deal on May 02 ’24 to sell 462.0 shares. Meanwhile, Director Ganot Ilan sold 139.0 shares on Jan 29 ’24.
